Results 271 to 280 of about 498,772 (347)
Network Pharmacology and Transcriptome Analysis Reveal Potential Cardiometabolic Targets of <i>Polygonum cuspidatum</i>. [PDF]
Oh J, Choo J, Yang G, Chu H, An WG.
europepmc +1 more source
Engineering an immune-integrated lung-on-a-chip to reveal TOX-RAGE axis-driven fibrosis and RAGE blockade as a therapeutic strategy. [PDF]
Kim H +8 more
europepmc +1 more source
The HMGB1/RAGE/β-catenin axis mediates aberrant osteogenic-tenogenic differentiation imbalance of tendon stem/progenitor cells in diabetic tendinopathy. [PDF]
Lu P, Gao Y, Wang H, Shi L, Li Y, Rui Y.
europepmc +1 more source
Exploratory pilot trial of astaxanthin supplementation in PCOS patients at risk of OHSS with focus on RAGE-NFκB pathway. [PDF]
Maleki-Hajiagha A, Aleyasin A, Amidi F.
europepmc +1 more source
The Receptor for Advanced Glycation End-Products (RAGE) Regulates Cell Adhesion Through Upregulation of ITGA8. [PDF]
Thiyagarajan S, Leclerc E, Vetter SW.
europepmc +1 more source
Pathophysiology of RAGE in inflammatory diseases
The receptor for advanced glycation end products (RAGE) is a non-specific multi-ligand pattern recognition receptor capable of binding to a range of structurally diverse ligands, expressed on a variety of cell types, and performing different functions ...
H. Dong, Yue Zhang, Yu Huang, H. Deng
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Critical reviews in food science and nutrition, 2022
Advanced glycation end products (AGEs) are formed in non-enzymatic reaction, oxidation, rearrangement and cross-linking between the active carbonyl groups of reducing sugars and the free amines of amino acids.
Yueqin Li +5 more
semanticscholar +1 more source
Advanced glycation end products (AGEs) are formed in non-enzymatic reaction, oxidation, rearrangement and cross-linking between the active carbonyl groups of reducing sugars and the free amines of amino acids.
Yueqin Li +5 more
semanticscholar +1 more source

